Thrombosis, major bleeding, and mortality in 1079 patients with myelofibrosis: a matched population-based study.

Blood Adv · 2025 · PMC12167804 · PMID 40117492

Europe PMC DOI

hedged sentences

0.1200

closest p · 2.4× alpha

0.2000

boldest claim

The sentences

failed to reach statistical significanceP = .12not close (p > 0.1)

The presence of a JAK2 V617F mutation failed to reach statistical significance as a risk factor for arterial or venous events (HR, 1.38; 95% CI, 0.92-2.07; P = .12; supplemental Table 4 ).

also in 6,035 other papers

did not reach statistical significanceP = .20not close (p > 0.1)

The use of antiplatelet agents, anticoagulants, or LMWH did not reach statistical significance as risk factors for major bleeding, with HRs of 0.73 (95% CI, 0.45-1.18; P = .20), 0.81 (95% CI, 0.43-1.55; P = .53), and 1.64 (95% CI, 0.64-4.17; P = .30), respectively.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.